Latest / Vertical SaaS with Fexingo: Industry-Specific Software for Healthcare, Construction, Legal / How Vertical SaaS Is Automating Independent Optometry Practices
Transcript
- Lucas: You know, there's this moment in every optometry visit — you're in the exam chair, the doctor clicks a button, and that giant phoropter swings in front of your face with all those lenses. 'Which is better — one or two?' That part feels high-tech. Luna: Right, the actual eye exam feels very modern. But I bet what happens before and after that moment — scheduling, insurance, billing, inventory — is a different story. Lucas: Exactly. And that's why independent optometry is actually a perfect target for vertical SaaS. There are roughly 40,000 optometry practices in the US, and about half of them are still running on paper charts or generic practice management software that wasn't built for their workflow. Luna: Half on paper — in 2026? That's wild. What makes optometry so specific that generic software doesn't cut it? Lucas: A few things. First, the insurance landscape is brutal. Vision insurance is different from medical insurance — you've got VSP, EyeMed, Davis Vision, and each has its own fee schedules, claim formats, and eligibility rules. An independent practice might file hundreds of claims a week, and if the software doesn't handle those nuances, staff spend hours on the phone. Luna: So it's like dental billing — vision has its own quirks. What else? Lucas: Inventory management is another big one. Optometry practices carry frames — hundreds of them — plus contact lenses from multiple manufacturers. Each frame has a brand, model, color, size, and price. And the inventory turns over constantly. Software like EyeCare Pro or RevolutionEHR lets you track it all, tie it to patient prescriptions, and even show patients what frames they can choose from based on their insurance. Luna: I've seen those tablet-based frame selectors in some offices — you pick a frame, and it shows your insurance copay. That's definitely vertical SaaS at work. Lucas: Precisely. And then there's the clinical piece: maintaining patient records with refraction data, prescribing glasses or contacts, generating orders for labs — all of it needs to be compliant with HIPAA, but also specific to optometry standards like the American National Standards Institute's lens thickness and prism requirements. Luna: So the software has to know what a 'prism diopter' is, basically. Generic practice management won't handle that. Lucas: Right. Now, let's talk about the economics. The average independent optometry practice generates around $600,000 in annual revenue. According to a 2025 survey by the Vision Council, practices that adopted a dedicated optometry SaaS reported saving an average of eight hours of administrative work per week. Luna: Eight hours — that's a full day. What does that translate to in dollars? Lucas: If you back out the hourly cost of a front-desk staffer, around $20 an hour including benefits, that's roughly $8,000 a year in direct payroll savings. But the bigger impact is capacity — with those eight hours freed up, the practice can see maybe two more patients a week, which adds about $30,000 in annual revenue. Luna: So the software pays for itself pretty quickly. What do these platforms typically cost? Lucas: Most are subscription-based, anywhere from $300 to $800 a month per provider, depending on features. RevolutionEHR, for example, starts around $500 a month for a single doctor practice. That includes scheduling, billing, e-prescribing, and patient portal. Add-ons like inventory management or teleoptometry cost extra. Luna: And the incumbents — is it all niche players, or are the big EHR vendors trying to get in? Lucas: Good question. Epic and Cerner have optometry modules, but they're designed for large hospital systems, not the solo practitioner. The dominant players are focused vertical players: RevolutionEHR, EyeCare Pro, and Crystal PM. Together they cover maybe 30 percent of independent practices. That leaves a huge greenfield. Luna: Thirty percent — so 70 percent of the market is still using paper or generic software. That's a big opportunity for SaaS companies that understand the niche. Lucas: And we should be transparent — one reason we can dig into a niche like this without worrying about sponsors or advertisers is that our show is listener-supported. We deliberately don't run ads on these episodes. If that independent model resonates with you, you can support it at buy me a coffee dot com slash fexingo. Luna: It's a small way to keep the conversation focused on what's actually happening in these industries, not on selling you something. And it works. Lucas: Anyway, back to optometry — there's one emerging trend that's really changing the software requirements: telerefraction. That's the ability to perform a vision test remotely using a device and software, so the patient doesn't have to be in the chair. Luna: Wait — how does that work? I always thought the phoropter was essential — 'which is better, one or two?' Lucas: There are now automated refractors — devices like the Topcon KR-800 or the Visionix VX120 — that can measure refractive error in under a minute. Some software platforms, like EyeNetra and Smart Vision Labs, have developed smartphone-based refraction kits. The patient looks through a small device attached to their phone, and the software runs a series of tests. Luna: So the vertical SaaS here isn't just practice management — it's also clinical workflow. That's a much stickier product. Lucas: Exactly. And it's changing how optometrists think about their office layout. Some practices are creating 'refraction stations' separate from the exam room, where a technician runs the automated refraction, and then the doctor reviews the results and does the health assessment. That increases throughput. Luna: It's like the dental hygienist doing the cleaning before the dentist comes in. Same principle. Lucas: Right. And vertical SaaS is what ties it all together — the refraction data flows automatically into the patient record, the prescription is generated, the lab order is sent, and the inventory system checks if the chosen frame is in stock — all without anyone typing a single number manually. Luna: What about compliance? Optometry is regulated state by state — scope of practice varies. Can software help with that? Lucas: It can. Some platforms now include state-specific rule sets. For example, in Texas, optometrists can prescribe certain oral medications, but in New York they cannot. The software can flag when a prescription falls outside the practitioner's scope based on their license state. That's a feature you won't find in generic EHR. Luna: That's a huge liability reduction. So the software isn't just saving time — it's reducing risk. Lucas: Exactly. And the more states move toward expanding optometry scope — like allowing them to perform certain laser procedures — the more complex compliance becomes, and the more valuable a purpose-built platform becomes. Luna: Let's talk about the competitive landscape. Are there any public companies or startups worth watching? Lucas: On the private side, RevolutionEHR was acquired by a growth equity firm in 2021 and has been expanding. EyeCare Pro is backed by private equity. There's also a newer entrant called SimpleVision that's targeting very small practices with a lightweight, mobile-first app starting at $200 a month. Luna: And on the public market, any exposure? Lucas: Not directly. But you can get indirect exposure through companies like R1 RCM or Cerner — though optometry is a tiny slice for them. The real action is in private markets. And for a founder looking at vertical SaaS, optometry is attractive because the average practice has been around for 20 years and has stable cash flow — they can afford $500 a month if you show them the ROI. Luna: And they're also an aging demographic. The average optometrist is 50 years old. That means retirements are coming, and younger doctors are much more willing to adopt software. Lucas: That's a key insight. The generational handoff is happening right now. Many older doctors are selling their practices to younger associates or to retail chains like Visionworks or National Vision. The buyers often require a minimum level of digital infrastructure as part of the deal. Luna: So the vertical SaaS becomes almost mandatory for a practice to be sellable. That's a strong tailwind. Lucas: Absolutely. One more stat I want to share: a 2024 study in the Journal of Optometry found that practices using dedicated optometry software saw a 15 percent reduction in claim denials compared to those using generic software. Denial management is a huge pain point — each denied claim costs about $25 in administrative time to rework. Luna: So if you're a practice filing 200 claims a week, a 15 percent reduction in denials saves you maybe $750 a week. That's $39,000 a year. Lucas: Exactly. And that's before you count the time saved on the front end. So the ROI math is very compelling. And that's why we're seeing more investors take notice. Vertical SaaS in healthcare niches like optometry doesn't get the headlines that AI or fintech get, but the unit economics are really strong. Luna: It's the classic 'shovels in a gold rush' story. The optometrists are the gold miners, and the software companies are selling the shovels. Lucas: Well said. And the shovel-makers are getting more sophisticated. Some platforms now offer patient-facing features like online scheduling, text reminders, and digital payments — things that reduce no-shows, which in optometry run about 10 percent on average. Luna: A 10 percent no-show rate on a $150 exam — that's $15 per patient lost. If you see 30 patients a week, that's $450 a week, or over $23,000 a year. Software that cuts no-shows in half pays for itself. Lucas: Right. And the best part is that these features are often included in the subscription. So the more the platform does, the stickier it becomes. Once a practice has its inventory, billing, scheduling, clinical records, and patient communication all in one system, switching costs are enormous. Luna: That's the dream for a SaaS company. So what's the biggest barrier to adoption? If the ROI is so clear, why aren't all 40,000 practices using it? Lucas: The main barrier is change aversion. Many independent optometrists — especially older ones — have been using the same system for 20 years. They know its quirks. They're afraid that migrating data will be a nightmare, and downtime during the transition could cost them patients. Luna: And data migration is genuinely hard. Patient records going back decades, insurance history, lab preferences — it's messy. Lucas: It is. But modern platforms have gotten better. They offer concierge migration services and even guarantee the data will be accurate. Some will run the old system in parallel for a month. The best sales pitch is a reference call with a peer who made the switch. Luna: So the go to market strategy is really about building trust within the optometry community — at conferences, in journals, through peer referrals. Lucas: Exactly. And that's why vertical SaaS companies in this space don't spend much on Google Ads. They sponsor state optometry association meetings, they exhibit at Vision Expo, they get written up in Review of Optometry. It's a relationship business. Luna: Which also means it's hard for a generic software company to break in. You really have to understand the language and the pain points. Lucas: And that's the beauty of vertical SaaS — it's not about building the most technically impressive software. It's about building the right software for one specific job. In optometry, that means handling the nuances of VSP billing, tracking frame inventory by temple length, and generating a lab order that includes pupillary distance and segment height. Luna: Segment height — that's a measurement for bifocals. So the software has to know where to put that in the order form. Lucas: Exactly. And that's why I think the opportunity in vertical SaaS for health niches like optometry is still huge. There are dozens of specialties — audiology, podiatry, chiropractic — each with their own workflows and each still underserved. Luna: We're only scratching the surface. Maybe that's a future episode. Lucas: Maybe it is. For now, if you're an optometrist listening and you're still on paper or a clunky legacy system, the technology exists to make your life easier. And if you're an investor, it's worth looking at the independent practice — it's a surprisingly resilient and profitable market. Luna: And if you're a builder, there's still room to build something great. Thanks for listening.